Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis

Multiple Sclerosis (MS) Clinical Trial

— HLGI  

Official title:

Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03177655
• Other study ID #: 121412
• Status: Completed
• Phase: N/A
• First received: May 31, 2017
• Last updated: June 5, 2017
• Start date: March 1, 2012
• Est. completion date: March 1, 2017

Study information

• Verified date: June 2017
• Source: University of California, San Diego
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This single-center interventional study quasi-randomly allocated patients to a guided imagery or control intervention (positive journaling). Data were analyzed with treatment allocation masked.

Description:

Interventions: Participants were assigned in alternate order to 10 weekly 1-hour sessions "Healing Light Guided Imagery" or at-home positive journaling; drop-outs were replaced.

Intervention Type: Behavioral

Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord (central nervous system). Because nerves in any part of the brain or spinal cord may be damaged, patients with multiple sclerosis can have symptoms in different parts of the body. Many Multiple Sclerosis patients suffer from depression, fatigue and anxiety in addition to physical symptoms. Drugs prescribed for MS have been shown to not improve these comorbid psychological symptoms. Researchers have shown that mindfulness-based training programs can help MS patients, but these therapies are highly resource demanding and taxing for those involved. "Healing Light" Guided Imagery (HLGI; supplementary materials) is a guided imagery therapy that simulates a self-hypnotic trance state that has been anecdotally shown to improve depression and fatigue in patients with MS in less time and with fewer support resources. The investigators plan to test whether HLGI can increase patient well-being.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: March 1, 2017
• Est. primary completion date: March 1, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

1. Diagnosis of Relapsing-Remitting Multiple Sclerosis

2. 18-70 years old

3. Able to read and write in English

4. Able to attend sessions at the UC San Diego School of Medicine

• Age group: adult

• Gender: both

• Target enrollment: 20

Participant exclusion criteria:

1. Severe depression (score of 31 or higher on the BDI)

2. Very high levels of fatigue (above an average of 6 on the FSS)

3. Low levels of mindfulness (below an average score of 2 on the FMI).

Related Conditions & MeSH terms

• Multiple Sclerosis
• Multiple Sclerosis (MS)
• Sclerosis

Intervention

Other:
• Guided Imagery
Guided Imagery meditation
• Journaling
Keeping a journal

Locations

Country	Name	City	State
United States	University of California, San Diego	San Diego	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, San Diego

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of Life (MS-QOL-54)	Quality of Life based on Multiple Sclerosis Quality of Life Instrument (MS-QOL-54)	Change from baseline at 10 weeks
Secondary	Mood (BDI-II)	Depressed mood based on the Beck Depression Inventory II (BDI-II)	Change from baseline at 10 weeks
Secondary	Fatigue (FSS)	Fatigue levels based on the Fatigue Severity Scale (FSS)	Change from baseline at 10 weeks